Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIp Group Regulatory News (IPO)

Share Price Information for Ip Group (IPO)

Share Price is delayed by 15 minutes
Get Live Data
66.20    -1.80 (-2.65%)
Bid:
65.90
Ask:
66.70
Spread: 0.80 (1.214%)
Market Cap: £584.83m
IPO Live PriceLast checked at - London Stock Exchange

Intraday Ip Group Share Chart

Director Declaration

31 Oct 2018 17:52

RNS Number : 9462F
IP Group PLC
31 October 2018
 

FOR RELEASE ON

31 October 2018

 

IP Group plc - Director declaration

 

IP Group plc (LSE: IPO) ("IP Group" or "the Group"), the developer of intellectual property-based businesses, notes that Sir Douglas Flint, Non-executive Chairman, will be appointed as a Non-Executive Director and Chairman Designate of Standard Life Aberdeen plc from 1 November 2018.

 

This disclosure is made in accordance with LR 9.6.14R of the Listing Rules.

 

For more information, please contact:

 

IP Group plc

www.ipgroupplc.com

Alan Aubrey, Chief Executive OfficerGreg Smith, Chief Financial OfficerLiz Vaughan-Adams, Communications

+44 (0) 20 7444 0050+44 (0) 20 7444 0062/+44 (0) 7979 853802

Charlotte Street Partners

Andrew Wilson

+44 (0) 7810 636995

Martha Walsh

+44 (0) 7876 245962

Tom Gillingham

+44 (0) 7741 659021

 

Notes for editors

 

About IP Group

 

IP Group is a leading intellectual property commercialisation company which focuses on evolving great ideas, mainly from its partner universities, into world-changing businesses. The Group has pioneered a unique approach to developing these ideas and the resulting businesses by providing access to business building expertise, capital (through its 100%-owned FCA-authorised subsidiaries IP Capital and Parkwalk Advisors), networks, recruitment and business support. IP Group has a strong track record of success and its portfolio comprises holdings in early-stage to mature businesses across life sciences and technology. IP Group is listed on the Main Market of the London Stock Exchange under the code IPO.

 

For more information, please visit our website at www.ipgroupplc.com.

 

ENDS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RDNFKDDPOBDDKKN
Date   Source Headline
15th Jan 20253:21 pmRNSForm 8.3 - Tissue Regenix Group plc
15th Jan 20257:00 amRNSTransaction in Own Shares
14th Jan 20257:00 amRNSTransaction in Own Shares
10th Jan 20256:02 pmRNSTransaction in Own Shares
10th Jan 20257:00 amRNSTransaction in Own Shares
9th Jan 20257:00 amRNSShare buyback programme update
8th Jan 20257:00 amRNSTransaction in Own Shares
6th Jan 20255:43 pmRNSTransaction in Own Shares
31st Dec 20247:00 amRNSTotal Voting Rights
20th Dec 20245:09 pmRNSTransaction in Own Shares
20th Dec 20241:46 pmRNSForm 8.3 - Intelligent Ultrasound Group plc
20th Dec 20247:00 amRNS-RTwo life sciences companies receive cash offers
20th Dec 20247:00 amRNSTransaction in Own Shares
19th Dec 20241:10 pmRNS£119m initial cash after sale of Featurespace
18th Dec 20246:26 pmRNSTransaction in Own Shares
18th Dec 20247:00 amRNSTransaction in Own Shares
16th Dec 20244:55 pmRNSTransaction in Own Shares
13th Dec 20245:59 pmRNSTransaction in Own Shares
13th Dec 20247:00 amRNSTransaction in Own Shares
12th Dec 20247:00 amRNSAGM post-meeting shareholder engagement update
12th Dec 20247:00 amRNSTransaction in Own Shares
11th Dec 20247:00 amRNSTransaction in Own Shares
10th Dec 20247:00 amRNSTransaction in Own Shares
9th Dec 20242:44 pmRNSHolding(s) in Company
9th Dec 202412:00 pmRNSHolding(s) in Company
9th Dec 20247:00 amRNSSecondary sale of minority holdings in portfolio
6th Dec 20245:13 pmRNSTransaction in Own Shares
6th Dec 20241:57 pmRNSForm 8.3 - Tissue Regenix Group plc
6th Dec 20247:00 amRNSTransaction in Own Shares
3rd Dec 20245:18 pmRNSTransaction in Own Shares
3rd Dec 20247:00 amRNSTransaction in Own Shares
2nd Dec 20241:35 pmRNSHolding(s) in Company
2nd Dec 20247:01 amRNSTotal Voting Rights
2nd Dec 20247:00 amRNSTransaction in Own Shares
29th Nov 20247:00 amRNSTransaction in Own Shares
27th Nov 20246:16 pmRNSTransaction in Own Shares
27th Nov 20247:00 amRNSTransaction in Own Shares
25th Nov 20246:09 pmRNSTransaction in Own Shares
25th Nov 20247:00 amRNSTransaction in Own Shares
22nd Nov 20247:00 amRNSTransaction in Own Shares
21st Nov 20247:00 amRNSTransaction in Own Shares
20th Nov 20247:00 amRNSTransaction in Own Shares
19th Nov 20247:00 amRNSTransaction in Own Shares
15th Nov 20245:59 pmRNSTransaction in Own Shares
15th Nov 20248:45 amRNSForm 8.3 - Tissue Regenix Group plc
15th Nov 20247:00 amRNSTransaction in Own Shares
13th Nov 20245:10 pmRNSTransaction in Own Shares
13th Nov 20247:00 amRNSTransaction in Own Shares
12th Nov 20247:00 amRNSTransaction in Own Shares
8th Nov 20245:17 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.